Glen Industries P/B Ratio
Current P/B Ratio
1.42
Moderate Valuation
Moderate - Reasonably valued relative to book value
Glen Industries (GLEN) P/B ratio is 1.42 (Moderate), book value per share ₹32.78 vs Healthcare average P/B of -0.94 — Moderate - Reasonably valued relative to book value. Compare with GLEN fair value estimate to assess whether the stock is under or overvalued.
Current Valuation Metrics
P/B Ratio
1.42
Current Price
₹
Book Value/Share
₹32.78
Exchange
None
Book Value Breakdown (2025)
Balance Sheet Components
Total Equity
₹59 Cr
Share Capital
₹18 Cr
Reserves & Surplus
₹41 Cr
Outstanding Shares
18,000,000
Book Value per Share
₹32.78
Valuation Signal
Signal
Fairly Valued
Sector Context
Sector Average
-0.94
Sector Median
0.6
Sector Rank
#11 of 50
Sector Percentile
22.0%
GLEN P/B Ratio — Valuation Insights & Book Value Analysis
Glen Industries price-to-book ratio interpretation, valuation status and historical context — current P/B 1.42 (Moderate). For live price, earnings yield and the full fundamental profile, see GLEN stock price BSE.
- Trading at premium to sector average PB of -0.94
GLEN vs Healthcare Peers — P/B Ratio Comparison
Glen Industries P/B 1.42 vs Healthcare average -0.94, median 0.6 — range -31.21–1.03.
Sector Average
-0.94
Sector Median
0.6
Lowest P/B
-31.21
Highest P/B
1.03
Companies
50
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -31.21 | ₹25 | Low |
| Sun Pharma Advanced Rese… | SPARC | -16.05 | ₹5,310 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.31 | ₹75 | Low |
| Parmax Pharma | PARMAX | -2.16 | ₹12 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.76 | ₹121 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |